VGV: N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)cyclohexanecarboxamide
VGV is a Ligand Of Interest in 8DQF designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 8DQF_VGV_C_301 | 87% | 1% | 0.091 | 0.97 | 2.81 | 5.71 | 9 | 17 | 2 | 0 | 100% | 1 |
| 8DQF_VGV_E_301 | 86% | 0% | 0.092 | 0.967 | 2.81 | 7.06 | 7 | 19 | 2 | 0 | 100% | 1 |
| 8DQF_VGV_A_301 | 86% | 1% | 0.095 | 0.97 | 2.37 | 6.06 | 6 | 20 | 2 | 0 | 100% | 1 |
| 8DQF_VGV_G_301 | 85% | 0% | 0.095 | 0.967 | 2.39 | 6.42 | 7 | 18 | 3 | 0 | 100% | 1 |
| 7JOB_VGV_A_302 | 88% | 0% | 0.091 | 0.974 | 6.18 | 6.26 | 15 | 20 | 2 | 0 | 100% | 1 |
| 7JNZ_VGV_A_303 | 81% | 0% | 0.109 | 0.969 | 6.36 | 6.64 | 17 | 20 | 3 | 0 | 100% | 1 |